Supplement: Novel Cancer Immunotherapy Combos – Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News |
Supplement: Novel Cancer Immunotherapy Combos
Genetic Engineering & Biotechnology News Immunotherapy drugs, such as antibodies, make cancer cells more vulnerable to destruction by T cells. The leading immunotherapy drugs are checkpoint inhibitors, which act on immune checkpoints, molecular pathways that evolved to prevent T cells from … |
